5-Methylindole-2-carboxylic acid, 99%
5-Methylindole-2-carboxylic acid, 99%
5-Methylindole-2-carboxylic acid, 99%
5-Methylindole-2-carboxylic acid, 99%
Thermo Scientific Chemicals

5-Methylindole-2-carboxylic acid, 99%

CAS: 10241-97-1 | C10H9NO2 | 175.19 g/mol
Have Questions?
Change viewbuttonViewtableView
Quantity:
1 g
5 g
Catalog number L17145.06
also known as L17145-06
Price (EUR)
274,00
Each
Add to cart
Quantity:
5 g
Request bulk or custom format
Price (EUR)
274,00
Each
Add to cart
Chemical Identifiers
CAS10241-97-1
IUPAC Name5-methyl-1H-indole-2-carboxylic acid
Molecular FormulaC10H9NO2
InChI KeyDAITVOCMWPNFTL-UHFFFAOYSA-N
SMILESCC1=CC=C2NC(=CC2=C1)C(O)=O
View more
SpecificationsSpecification SheetSpecification Sheet
Appearance (Color)Yellow or cream to pale brown
FormPowder
Assay (Aqueous acid-base Titration)≥98.5 to ≤101.5%
Assay (HPLC)≥98.5%
5-Methylindole-2-carboxylic acid is a compound used in the synthesis of Pin1 inhibitors as potential antitumor agents. reactant in preparation of Pin1 inhibitors as potential antitumor agents reactant in preparation of non-imidazole human histamine H4 receptor antagonists

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
5-Methylindole-2-carboxylic acid is a compound used in the synthesis of Pin1 inhibitors as potential antitumor agents. reactant in preparation of Pin1 inhibitors as potential antitumor agents reactant in preparation of non-imidazole human histamine H4 receptor antagonists

Solubility
Soluble in ethanol (50 mg/ml). Insoluble in water.

Notes
Keep container tightly closed. Store away from oxidizing agents.
RUO – Research Use Only

General References:

  1. Anja Lüth.; Werner Löwe. Syntheses of 4-(indole-3-yl)quinazolines - A new class of epidermal growth factor receptor tyrosine kinase inhibitors. European Journal of Medicinal Chemistry. 2008, 43 (7), 1478-1488.
  2. Takumi Tanaka.; Yoshihiro Minematsu.; Christopher F. Reilly.; James Travis.; James C. Powers. Human leukocyte cathepsin G. Subsite mapping with 4-nitroanilides, chemical modification, and effect of possible cofactors. Biochemistry. 1985, 24 (8), 2040-2047.